Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Altamira Therapeutics Ltd (CYTO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Altamira Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.420 -0.090    -5.96%
11:15:21 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 10,430
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.420 - 1.477
Altamira Therapeutics 1.420 -0.090 -5.96%

Altamira Therapeutics Ltd Company Profile

 
Get an in-depth profile of Altamira Therapeutics Ltd, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

16

Equity Type

ORD

Altamira Therapeutics Ltd. operates as a preclinical-stage biopharmaceutical company in Switzerland and Australia. The company develops and supplies OligoPhore/SemaPhore platforms, which are peptide-based nanoparticle technologies for ribonucleic acid delivery to extrahepatic tissues. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is developing AM-401 for the treatment of KRAS driven cancer; AM-411 for the treatment of rheumatoid arthritis; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase II/III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treatment of acute inner ear hearing loss. It also offers Bentrio, a drug-free nasal spray for protection against airborne viruses and allergens. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. The company was founded in 2003 and is based in Hamilton, Bermuda.

Contact Information

Address Clarendon House 2 Church Street
Hamilton, HM 11
Bermuda
Phone 441 295 5950
Fax -

Top Executives

Name Age Since Title
David Baguley - 2019 Member of Tinnitus's Scientific Advisory Board
Hinrich Staecker - 2019 Member of Tinnitus's Scientific Advisory Board
Wolfgang Arnold 81 2007 Member of Tinnitus's Scientific Advisory Board
Alain H. Munoz 74 2018 Independent Non-Executive Director
Mats Peter Blom 58 2017 Independent Non-Executive Director
Margrit Schwarz 59 2021 Independent Director
Richard Salvi - 2019 Member of Tinnitus's Scientific Advisory Board
Thomas Meyer 56 2003 Founder, President, Chairman, CEO & MD
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CYTO Comments

Write your thoughts about Altamira Therapeutics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sam Hafez
Sam Hafez Dec 13, 2023 12:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i guess the technial missed up on that one hahahahaha it was trading at .21 cents yesterday with stronge sell today jumped to 5:7 $ 🤣🤣🤣🤣 i ll never listen to yoy guys again
John Berry
John Berry May 04, 2023 8:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i gave you two 100% runners in a month. CNSP and CYTO. Start listening
John Berry
John Berry May 02, 2023 6:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Better load up. Its coming
John Berry
John Berry May 02, 2023 4:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Over 2 by end of next week..Watch and see
John Berry
John Berry Apr 26, 2023 3:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
May wanna get in..110% short interest and the CEO about to blow them up
John Berry
John Berry Apr 24, 2023 10:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's under $3 until it isn't
John Berry
John Berry Apr 24, 2023 9:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Starting to get fun this week
John Berry
John Berry Apr 24, 2023 9:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Starting to get fun this week
John Berry
John Berry Apr 21, 2023 5:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't say you weren't warned when this goes up 100%. Called CNSP BEFORE it went from .69 cents to 4+ a 300% winner
John Berry
John Berry Apr 19, 2023 8:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Here is your next double
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email